Back to All

Diaceutics CFO, Philip White named in The Business & Finance CFO 100 Index 2021

14 December, 2021

Diaceutics Chief Financial Officer, Philip White has been named in The Business & Finance CFO 100 Index 2021, which recognises the top 100 Chief Financial Officers working across some of the most innovative companies in Ireland and the UK.

The CFO Index celebrates CFO's who are constantly adapting, innovating and evolving in their role through leading high-performance teams, developing and perfecting processes, transforming organizations and using innovative technologies to not only survive but to succeed and thrive. 

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Diaceutics PLC


Philip White
Chief Financial Officer
+44 (0) 7801 611 921


Nominated adviser and broker

Stifel Nicolaus Europe Limited
150 Cheapside
London
EC2V 6ET.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane
London
EC4V 5EQ.

Tel: +44 (0)20 3405 0205 or [email protected]


 
Caroline Forde
Robyn Fisher
 
Kieran Breheny